Clinical Trials Directory

Trials / Completed

CompletedNCT05651529

Acute Oral Ketones or Carbohydrate Supplement Modify Heart Function in Heart Failure?

Does Oral Intake of Beta-hydroxybutyrate Decrease Left Ventricular End-systolic Volume at Cardiac Magnetic Resonance in Patients With Heart Failure Compared to Carbohydrate Placebo?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Does oral intake of exogenous ketone salt improve heart function measured by cardiac MRI in heart failure compared to oral intake of a carbohydrate placebo?

Detailed description

This study will help to quantify heart and kidney ketone uptake with or without an exogenous ketone salt in heart failure condition. Participants will have 2 different cardiac MRI to perform: 1. Fasting with exogenous ketone salt supplement 2. Fasting with exogenous carbohydrate supplement

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTexogenous ketone salt supplementDietary Supplement: Fasting water and with exogenous ketone salt supplement. Participants will have to take 1 doses of supplement 30 minutes before the scan.
DIETARY_SUPPLEMENTexogenous carbohydrate supplementDietary Supplement: Fasting water and with exogenous carbohydrate supplement. Participants will have to take 1 doses of supplement 30 minutes before the scan.

Timeline

Start date
2022-12-16
Primary completion
2025-12-16
Completion
2025-12-16
First posted
2022-12-15
Last updated
2026-01-07

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05651529. Inclusion in this directory is not an endorsement.